Skip to main content
DRIO
NASDAQ Industrial Applications And Services

DarioHealth Prices $23.5M Registered Direct Offering at $6.80, Board Member Participates

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$7.99
Mkt Cap
$57.768M
52W Low
$5.845
52W High
$17.744
52W Position info
37% above low
Off High info
55% below high
Rel. Volume info
15× avg
Market data snapshot near publication time

DRIO sits 37% above its 52-week low of $5.845 on elevated volume (15× avg).

Summary

DarioHealth priced a $23.5 million registered direct offering at $6.80 per share, a discount to the current $7.99 price, adding significant dilution to fund operations amid a going concern warning.


Key Events · Financing and Capital Events · DRIO

  • $23.5M Registered Direct Offering Priced

    Offering 2,451,490 common shares at $6.80 and 1,017,499 pre-funded warrants at $6.7999, for total gross proceeds of ~$23.6 million before fees.

  • Significant Dilution to Existing Holders

    The offering increases outstanding shares from 7.34 million to 9.79 million, a 33% increase, with additional dilution from pre-funded warrants exercisable at $0.0001.

  • Going Concern Context

    As of its Q1 2026 report, DarioHealth had substantial doubt about its ability to continue as a going concern; this raise provides near-term liquidity but does not resolve the underlying cash burn.

  • Board Member Participation

    A board member purchased 14,430 shares at $6.93 (~$100,000), a modest insider commitment alongside the offering.


Analysis · DRIO · Industrial Applications And Services

DarioHealth is raising $23.5 million in a registered direct offering priced at $6.80 per share — a discount to the current $7.99 price. The company had a going concern warning as of May 2026, and this capital injection is critical to extending its cash runway. However, the offering is highly dilutive: it adds 2.45 million common shares and 1.02 million pre-funded warrants, increasing the outstanding share count by roughly 33% before any warrant exercise. A board member's $100,000 participation at $6.93 provides a modest insider endorsement, but the deep discount and the 'reasonable best efforts' structure with no minimum underscore the company's precarious financial position. The net proceeds of ~$23.6 million will be used for working capital and general corporate purposes, buying time but not solving the underlying cash burn problem.

At the time of this filing, DRIO was trading at $7.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $57.8M. The 52-week trading range was $5.84 to $17.74. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DRIO - Latest Insights

DRIO
Jul 22, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
DRIO
Jul 10, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
7
DRIO
Jul 06, 2026, 7:30 AM EDT
Source: PR Newswire
Importance Score:
8
DRIO
Jul 02, 2026, 7:30 AM EDT
Source: PR Newswire
Importance Score:
9
DRIO
Jun 29, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8